| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab78a8f3306d62ee87a40db7144ffd85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72e1e7829aa4bfdf66f8e34f875c6554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e1018b924ad1e238642eaad9d2172a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2613944636ab2fdf3f83ef2d4b304f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a28ee0548823795bce5b4faf03cb2678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79f360e7161b6feffe60dd87f90989ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f23a5cf51c643cee68f322420fd63ddd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L3-3571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L3-34635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2005-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4382f20eab1ecb227e475aa1af4cb593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5af64afb3b2ec32730e8cdd5b9f6b1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc42c6bb67d256f9cb43b860254325ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_362b1d646833034637b7b92b89b57b69 |
| publicationDate |
2006-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006053445-A1 |
| titleOfInvention |
Lactic acid bacteria-derived bacteriocin and uses thereof for prevention or treatment of cancer |
| abstract |
Methods of preventing or treating cancer and of inhibiting proliferation of cancerous cells are disclosed herein. These methods comprise administering to an animal a bacteriocin derived from a lactic acid bacteria and/or a composition comprising a bacteriocin derived from a lactic acid bacteria and a carrier. In an embodiment, the bacteriocin may be cytotoxic to the cancerous cells. Also described herein are corresponding uses of these bacteriocins and compositions as well as packages comprising these bacteriocins and compositions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633437-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10946050-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012145185-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116370605-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116370605-A |
| priorityDate |
2004-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |